drugset / Trial / NCT02941796

Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers

NCT02941796 ↗

Phase 1 Completed 68 enrolled Hanmi Pharmaceutical Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the pharmacokinetic properties and safety after administration of HCP1105 and co-administration of HGP0918, HGP0816 in healthy male volunteers

Timeline

Start
2016-06
Primary completion
2016-07
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject HCP0816 Unknown — —
Subject HCP0918 Unknown — —
Subject HCP1105 Unknown — —

Indications